Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Global Bio-chem Technology Group Co Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), Global Bio-chem Technology Group Co Ltd tiene un total de activos de $4,542, una ganancia neta profit de $769

Question 2

¿Cuáles son los ratios financieros clave para GBCMF?

Accepted Answer

El ratio corriente de Global Bio-chem Technology Group Co Ltd es 0.69, el margen neto es 38.43, las ventas por acción son $0.07.

Question 3

¿Cómo se desglosan los ingresos de Global Bio-chem Technology Group Co Ltd por segmento o geografía?

Accepted Answer

Global Bio-chem Technology Group Co Ltd largest revenue segment is Amino Acids, at a revenue of 1,736,944,000 in the most earnings release.For geography, China is the primary market for Global Bio-chem Technology Group Co Ltd, at a revenue of 1,369,017,000.

Question 4

¿Es rentable Global Bio-chem Technology Group Co Ltd?

Accepted Answer

yes, según los últimos estados financieros, Global Bio-chem Technology Group Co Ltd tiene una ganancia neta profit de $769

Question 5

¿Tiene Global Bio-chem Technology Group Co Ltd alguna deuda?

Accepted Answer

yes, Global Bio-chem Technology Group Co Ltd tiene una deuda de 6,496

Question 6

¿Cuántas acciones en circulación tiene Global Bio-chem Technology Group Co Ltd?

Accepted Answer

Global Bio-chem Technology Group Co Ltd tiene un total de acciones en circulación de 8,875.73

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2,288	2,001	1,373	12	746	848
Revenue Growth (YoY)	42%	46%	11,342%	-98%	-12%	-81%
Cost of Revenue	2,002	1,810	1,330	5	698	774
Gross Profit	286	190	43	7	48	74
Selling, General & Admin	255	283	370	265	419	448
Research & Development	--	--	--	--	--	--
Operating Expenses	-863	1,102	607	747	1,003	1,340
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	748	745	3,701	-1,424	-409	-2,410
Income Tax Expense	-23	-23	-42	-46	25	22
Net Income	772	769	4,224	-1,443	-400	-2,429
Net Income Growth	-81%	-82%	-393%	261%	-84%	128%
Shares Outstanding (Diluted)	8,907.4	26,196.43	14,080.16	8,907.4	8,907.4	8,507.94
Shares Change (YoY)	0%	86%	57.99%	0%	5%	24%
EPS (Diluted)	0.08	0.02	0.3	-0.14	-0.04	-0.28
EPS Growth	-83%	-90%	-305%	225%	-84%	84%
Free Cash Flow	108	76	-94	-94	-501	-43
Free Cash Flow Per Share	0.01	0	0	-0.01	-0.05	0
Gross Margin	12.5%	9.49%	3.13%	58.33%	6.43%	8.72%
Operating Margin	50.26%	-45.52%	-41.07%	-6,158.33%	-128.01%	-149.29%
Profit Margin	33.74%	38.43%	307.64%	-12,025%	-53.61%	-286.43%
Free Cash Flow Margin	4.72%	3.79%	-6.84%	-783.33%	-67.15%	-5.07%
EBITDA	1,293	-683	-259	-409	-553	-810
EBITDA Margin	56.51%	-34.13%	-18.86%	-3,408.33%	-74.12%	-95.51%
D&A For EBITDA	143	228	305	330	402	456
EBIT	1,150	-911	-564	-739	-955	-1,266
EBIT Margin	50.26%	-45.52%	-41.07%	-6,158.33%	-128.01%	-149.29%
Effective Tax Rate	-3.07%	-3.08%	-1.13%	3.23%	-6.11%	-0.91%

Global Bio-chem Technology Group Co Ltd (GBCMF) Price

GBCMF Stock Price Chart

GBCMF Income

Follow-Up Questions